Chronic Total Occlusion Summit 2018

A Live Case Demonstration Course

FEBRUARY 15-16, 2018

New York Marriott Marquis I 1535 Broadway I New York, NY


Leading practitioners of percutaneous coronary intervention must become experts at recanalizing chronic total occlusions (CTOs), and with advanced techniques, success rates greater than 90% may be obtained. Achieving high success rates with minimal complications is dependent upon physicians being up-to-date on the most recent advances in operator technique, guidewire technology, and other adjunctive devices.

Bringing together leaders in the field of CTO, the Chronic Total Occlusion Summit: A Live Case Demonstration Course will be held in the heart of New York City.

Sessions will emphasize both advanced techniques and evidence-based medicine, with a heavy reliance on live case transmissions featuring the world’s leading experts in CTO PCI. Topics to be covered include:

Fundamentals of CTO PCI
Complex Retrograde and Antegrade CTO PCI
Complication Prevention and Management
How to Improve Outcomes Today
Newest CTO and Complex PCI Techniques and Technologies
Application of CTO PCI Techniques and Technologies in Non-CTO PCI Cases
2017 Essential CTO Updates
Live Case Transmissions
Edited Taped Case Presentations

Please note: CTO 2018 is not CME-accredited.


Learning Objectives

By the end of this course, participants should be able to:

  • Identify the pathobiologic and clinical considerations associated with successful recanalization of chronic total occlusions
  • Explain how advances in operator technique, guidewire technology, and new devices have improved success rates for chronic total occlusions
  • Describe advanced guidewire techniques and other adjunctive devices, including the retrograde technique
  • Integrate the latest recommendations on how to use new guidewires and devices to optimize procedural success, while minimizing complications

Target Audience

This program is designed for interventional cardiologists, endovascular specialists, clinical cardiologists, catheterization laboratory nurses, cardiovascular technologists, and other healthcare professionals with a special interest in the field of chronic total occlusion.

Activity Evaluation

Evaluation will address content, presentation, possible bias, and future educational needs.

Disclosure Statement

It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity.

Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage are not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.

Sunshine Act Compliance

This activity is not CME-accredited, and therefore, the supporters are required under the Sunshine Act (as part of the Affordable Care Act) to track and report all payments and transfers of value to US licensed physicians, including meals and expenses that are provided to you. In order to help supporters comply with the Sunshine Act, the names and contact information of all US and Canadian licensed physicians participating in this function will be provided to the supporters of this program.